A thermogenic botanical composition containing Citrus aurantifolia fruit rind and Theobroma cacao seed extracts improves body composition in overweight adults: a clinical investigation.

IF 3.5 4区 医学 Q2 FOOD SCIENCE & TECHNOLOGY
Food & Nutrition Research Pub Date : 2025-06-24 eCollection Date: 2025-01-01 DOI:10.29219/fnr.v69.12159
Amulya Chadalavada, Yean Kyoung Koo, SukJin Kim, Sudipta Veeramachaneni, Guru Ramanathan, Amulya Yalamanchi
{"title":"A thermogenic botanical composition containing <i>Citrus aurantifolia</i> fruit rind and <i>Theobroma cacao</i> seed extracts improves body composition in overweight adults: a clinical investigation.","authors":"Amulya Chadalavada, Yean Kyoung Koo, SukJin Kim, Sudipta Veeramachaneni, Guru Ramanathan, Amulya Yalamanchi","doi":"10.29219/fnr.v69.12159","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>CL19183, or Theolim™, is a novel, proprietary combination of standardized extracts of <i>Citrus aurantifolia</i> fruit rind and <i>Theobroma cacao</i> seeds. Earlier, CL19183 supplementation demonstrated thermogenic activity and weight loss in high-fat diet-induced obese rats. This randomized, double-blind, placebo-controlled, multicenter clinical study (RCT) assessed whether CL19183 supplementation reduced body weight (BW) and improved body composition (BC) in overweight adults.</p><p><strong>Methods: </strong>The present study recruited 120 overweight male and female subjects (25-55 years) [body mass index (BMI) of 25-29.9 kg/m<sup>2</sup>] and randomly assigned to receive daily either CL19183 (450 mg; <i>n</i> = 60) or a matched placebo (<i>n</i> = 60) over 16 weeks. The primary efficacy outcome measure was BW reduction in the intention-to-treat (ITT) population. Other efficacy measures included BC using Dual-energy X-ray absorptiometry (DEXA), waist and hip circumferences, resting metabolic rate (RMR) using indirect calorimetry, serum lipid profile, and serum biomarkers utilizing enzyme-linked immunosorbent assay (ELISA). The safety parameters were performed, including complete serum biochemistry, hematology, and urine analysis.</p><p><strong>Results: </strong>Post-trial, CL19183 supplementation resulted in significant reductions in BW (4.25 ± 1.35 vs. 0.96 ± 1.18 kg; <i>p</i> = 0.0001; CI [confidence interval]: 1.47, 8.59) and BMI (1.57 ± 0.53 vs 0.36 ± 0.46 kg/m<sup>2</sup>, <i>p</i> < 0.0001; CI: 0.87, 2.11), from baseline as compared to placebo. Similarly, total body fat (4.28 ± 1.56 vs. 0.85 ± 1.06 kg; <i>p</i> < 0.0001; CI: 2.35, 7.79) and fat percentage (<i>p</i> < 0.0001) were also reduced from baseline in the CL19183 group vs. placebo. At baseline, after a single dose of CL19183 administration and after 16 weeks, RMR was significantly increased (<i>p</i> < 0.0001 vs. placebo). After 8 and 16 weeks of supplementation, CL19183 significantly increased serum adiponectin and glucagon-like peptide-1 and decreased ghrelin levels vs. baseline and placebo. No major adverse events were reported.</p><p><strong>Conclusion: </strong>CL19183 supplementation was well-tolerated and led to significant BW reduction and improvements in BC over 16 weeks.</p>","PeriodicalId":12119,"journal":{"name":"Food & Nutrition Research","volume":"69 ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12255159/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Food & Nutrition Research","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.29219/fnr.v69.12159","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objective: CL19183, or Theolim™, is a novel, proprietary combination of standardized extracts of Citrus aurantifolia fruit rind and Theobroma cacao seeds. Earlier, CL19183 supplementation demonstrated thermogenic activity and weight loss in high-fat diet-induced obese rats. This randomized, double-blind, placebo-controlled, multicenter clinical study (RCT) assessed whether CL19183 supplementation reduced body weight (BW) and improved body composition (BC) in overweight adults.

Methods: The present study recruited 120 overweight male and female subjects (25-55 years) [body mass index (BMI) of 25-29.9 kg/m2] and randomly assigned to receive daily either CL19183 (450 mg; n = 60) or a matched placebo (n = 60) over 16 weeks. The primary efficacy outcome measure was BW reduction in the intention-to-treat (ITT) population. Other efficacy measures included BC using Dual-energy X-ray absorptiometry (DEXA), waist and hip circumferences, resting metabolic rate (RMR) using indirect calorimetry, serum lipid profile, and serum biomarkers utilizing enzyme-linked immunosorbent assay (ELISA). The safety parameters were performed, including complete serum biochemistry, hematology, and urine analysis.

Results: Post-trial, CL19183 supplementation resulted in significant reductions in BW (4.25 ± 1.35 vs. 0.96 ± 1.18 kg; p = 0.0001; CI [confidence interval]: 1.47, 8.59) and BMI (1.57 ± 0.53 vs 0.36 ± 0.46 kg/m2, p < 0.0001; CI: 0.87, 2.11), from baseline as compared to placebo. Similarly, total body fat (4.28 ± 1.56 vs. 0.85 ± 1.06 kg; p < 0.0001; CI: 2.35, 7.79) and fat percentage (p < 0.0001) were also reduced from baseline in the CL19183 group vs. placebo. At baseline, after a single dose of CL19183 administration and after 16 weeks, RMR was significantly increased (p < 0.0001 vs. placebo). After 8 and 16 weeks of supplementation, CL19183 significantly increased serum adiponectin and glucagon-like peptide-1 and decreased ghrelin levels vs. baseline and placebo. No major adverse events were reported.

Conclusion: CL19183 supplementation was well-tolerated and led to significant BW reduction and improvements in BC over 16 weeks.

含有柑橘果皮和可可树种子提取物的产热植物成分改善超重成年人的身体成分:一项临床研究。
背景与目的:CL19183,或Theolim™,是一种新型的专利组合,由柑橘果皮和可可种子的标准化提取物组成。早些时候,CL19183补充剂在高脂肪饮食诱导的肥胖大鼠中显示出产热活性和体重减轻。这项随机、双盲、安慰剂对照、多中心临床研究(RCT)评估了补充CL19183是否能降低超重成年人的体重(BW)和改善身体成分(BC)。方法:本研究招募了120名体重超重的男性和女性受试者(25-55岁)[体重指数(BMI) 25-29.9 kg/m2],随机分配每天接受CL19183 (450 mg;N = 60)或匹配的安慰剂(N = 60),持续16周。主要疗效指标是意向治疗(ITT)人群的体重降低。其他疗效测量包括双能x线吸收仪(DEXA)的BC、腰臀围、间接量热法的静息代谢率(RMR)、血脂谱和酶联免疫吸附试验(ELISA)的血清生物标志物。安全性参数包括完整的血清生化、血液学和尿液分析。结果:试验后,补充CL19183显著降低了体重(4.25±1.35 vs. 0.96±1.18 kg;P = 0.0001;CI[置信区间]:1.47,8.59)和BMI(1.57±0.53 vs 0.36±0.46 kg/m2, p < 0.0001;CI: 0.87, 2.11),与安慰剂相比。同样,总体脂(4.28±1.56 vs. 0.85±1.06 kg;P < 0.0001;与安慰剂相比,CL19183组的CI: 2.35, 7.79)和脂肪百分比(p < 0.0001)也较基线降低。在基线时,单剂量CL19183给药后和16周后,RMR显著增加(与安慰剂相比p < 0.0001)。在补充8周和16周后,与基线和安慰剂相比,CL19183显著增加了血清脂联素和胰高血糖素样肽-1,降低了胃饥饿素水平。无重大不良事件报告。结论:补充CL19183具有良好的耐受性,并在16周内显著降低体重和改善BC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Food & Nutrition Research
Food & Nutrition Research FOOD SCIENCE & TECHNOLOGY-NUTRITION & DIETETICS
CiteScore
5.20
自引率
9.10%
发文量
47
审稿时长
14 weeks
期刊介绍: Food & Nutrition Research is a peer-reviewed journal that presents the latest scientific research in various fields focusing on human nutrition. The journal publishes both quantitative and qualitative research papers. Through an Open Access publishing model, Food & Nutrition Research opens an important forum for researchers from academic and private arenas to exchange the latest results from research on human nutrition in a broad sense, both original papers and reviews, including: * Associations and effects of foods and nutrients on health * Dietary patterns and health * Molecular nutrition * Health claims on foods * Nutrition and cognitive functions * Nutritional effects of food composition and processing * Nutrition in developing countries * Animal and in vitro models with clear relevance for human nutrition * Nutrition and the Environment * Food and Nutrition Education * Nutrition and Economics Research papers on food chemistry (focus on chemical composition and analysis of foods) are generally not considered eligible, unless the results have a clear impact on human nutrition. The journal focuses on the different aspects of nutrition for people involved in nutrition research such as Dentists, Dieticians, Medical doctors, Nutritionists, Teachers, Journalists and Manufacturers in the food and pharmaceutical industries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信